当前位置:首页 - 行情中心 - 禾元生物-U(688765) - 财务分析 - 现金流量表

禾元生物-U

(688765)

  

流通市值:100.53亿  总市值:131.42亿
流通股本:2.73亿   总股本:3.58亿

现金流量表

报告期2026-09-302026-06-302026-03-312025-12-31
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金66,669,779.7533,834,137.4415,065,358.0156,017,967.1
  收到的税费返还239,225.98158,981.6893,543.561,107,161.4
  收到其他与经营活动有关的现金63,896,142.2930,402,700.064,135,658.497,027,306.72
  经营活动现金流入小计130,805,148.0264,395,819.1819,294,559.97154,152,435.22
  购买商品、接受劳务支付的现金147,200,299.8492,150,256.4434,883,707.0668,688,600.24
  支付给职工以及为职工支付的现金48,493,326.5434,079,943.2220,523,576.6251,027,056.99
  支付的各项税费4,074,523.572,677,032.551,730,099.032,207,161.13
  支付其他与经营活动有关的现金37,045,580.2730,746,804.3111,680,389.85160,548,582.24
  经营活动现金流出小计236,813,730.22159,654,036.5268,817,772.56282,471,400.6
  经营活动产生的现金流量净额-106,008,582.2-95,258,217.34-49,523,212.59-128,318,965.38
二、投资活动产生的现金流量:
  收回投资收到的现金479,830,000800,830,00075,000,000-
  取得投资收益收到的现金4,859,864.5---
  投资活动现金流入的平衡项目000-
  投资活动现金流入小计484,689,864.5800,830,00075,000,000-
  购建固定资产、无形资产和其他长期资产支付的现金508,427,274.52333,715,157.95233,847,042.4538,058,635.46
  投资支付的现金257,000,000--1,310,830,000
  投资活动现金流出小计765,427,274.52333,715,157.95233,847,042.41,848,888,635.46
  投资活动产生的现金流量净额-280,737,410.02467,114,842.05-158,847,042.4-1,848,888,635.46
三、筹资活动产生的现金流量:
  吸收投资收到的现金---2,456,908,042.2
  取得借款收到的现金322,299,205322,299,20524,900,000411,587,096.13
  筹资活动现金流入小计322,299,205322,299,20524,900,0002,868,495,138.33
  偿还债务支付的现金332,448,342.98332,199,342.9883,253,227.98321,809,094.47
  分配股利、利润或偿付利息支付的现金6,238,920.494,014,169.81,933,586.6914,495,870.06
  支付其他与筹资活动有关的现金4,924,4544,456,9542,060,00045,915,781.71
  筹资活动现金流出小计343,611,717.47340,670,466.7887,246,814.67382,220,746.24
  筹资活动产生的现金流量净额-21,312,512.47-18,371,261.78-62,346,814.672,486,274,392.09
四、汇率变动对现金及现金等价物的影响-42,908.96-26,615.02239.62-27,873.47
五、现金及现金等价物净增加额-408,101,413.65353,458,747.91-270,716,830.04509,038,917.78
  加:期初现金及现金等价物余额669,441,252.44669,441,252.44669,441,252.44160,402,334.66
  期末现金及现金等价物余额261,339,838.791,022,900,000.35398,724,422.4669,441,252.44
补充资料:
  净利润--62,756,540.53--157,037,347.83
  资产减值准备-960,008.16-705,891.77
  固定资产和投资性房地产折旧-29,262,100.8-59,075,705.14
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧-29,262,100.8-59,075,705.14
  无形资产摊销-1,301,432.1-2,802,836.08
  长期待摊费用摊销-364,957.3-723,013.23
  处置固定资产、无形资产和其他长期资产的损失--1,311,595.48--3,788,302.22
  财务费用-1,742,632.38-7,559,677.76
  投资损失--8,060,063.39--907,526.05
  存货的减少--123,819,282.07--73,339,498.69
  经营性应收项目的减少--40,122,796.42--77,559,983.99
  经营性应付项目的增加-93,501,420.27-86,510,149.25
  其他-8,581,239.67-23,156,127.89
  现金的期末余额-1,022,900,000.35-669,441,252.44
  减:现金的期初余额-669,441,252.44-160,402,334.66
  现金及现金等价物的净增加额-353,458,747.91-509,038,917.78
公告日期2026-10-282026-08-272026-04-282026-04-28
审计意见(境内)标准无保留意见
TOP↑